PanoptiveYC S25 landing page report.
← Back to YC S25

Score over time

7060504030CluePoints 52 on Apr 15 (Wayback)CluePoints 50 on May 13 (Wayback)CluePoints 51 on Jun 9 (Wayback)CluePoints 59 on Jul 6 (Wayback)CluePoints 55 on Jul 29 (Wayback)CluePoints 66 on Aug 13 (Wayback)CluePoints 62 on Sep 22 (Live)Remarque Systems 56 on Sep 22 (Live)TrialKey / Saama (Smart Data Quality) 59 on Apr 10 (Wayback)TrialKey / Saama (Smart Data Quality) 47 on Apr 20 (Wayback)TrialKey / Saama (Smart Data Quality) 54 on Sep 17 (Wayback)TrialKey / Saama (Smart Data Quality) 60 on Sep 20 (Live)Medidata Detect 42 on Jul 12 (Wayback)Medidata Detect 41 on Aug 10 (Wayback)Medidata Detect 46 on Aug 30 (Wayback)Medidata Detect 47 on Sep 9 (Wayback)Medidata Detect 58 on Sep 20 (Live)Veeva CDB / RBQM (Vault Clinical) 62 on Jun 2 (Wayback)Veeva CDB / RBQM (Vault Clinical) 44 on Jun 14 (Wayback)Veeva CDB / RBQM (Vault Clinical) 63 on Jun 27 (Wayback)Veeva CDB / RBQM (Vault Clinical) 61 on Jul 11 (Wayback)Veeva CDB / RBQM (Vault Clinical) 62 on Aug 4 (Wayback)Veeva CDB / RBQM (Vault Clinical) 52 on Sep 2 (Wayback)Veeva CDB / RBQM (Vault Clinical) 54 on Sep 20 (Live)Panoptive 65 on Sep 22 (Live)Sep 22

Trust

38Poor

Proof that the product is real, competent, and safe to try.

CluePoints
TrialKey / Saama (Smart Data Quality)
Medidata Detect
Veeva CDB / RBQM (Vault Clinical)
Trust read
PanoptiveNo visible trust signal identified.
CluePointsStats bar showing "18,900+", "2,800+", "320,000+" below the hero
Remarque SystemsNo visible trust signal identified.
TrialKey / Saama (Smart Data Quality)"Saama Wins “AI-based Life Sciences Solution of the Year” Award in 2026 AI Breakthrough Awards" banner
Medidata DetectWebinar card citing "expert discussion with Worldwide Clinical Trials" (mobile)
Veeva CDB / RBQM (Vault Clinical)Announcement banner: "Veeva Announces Falcon, Agentic Labor for Drug Development"

Mobile web

68Fair

The phone experience as a first-class citizen.

Mobile web annotations on the mobile capture123
  1. Primary CTA below fold — "Start a pilot" sits ~1100px down the viewport, pushed near or past the first screen edge on shorter phones.
  2. Stacked hero messages — Headline, four-line subhead, and a bolded second tagline compete before the visitor reaches any action.
  3. Start a pilot button — Desktop-proportioned width instead of a full-bleed, thumb-friendly bar; twinned with an equal-weight "See how it works" below it.

CTA

72Fair

Copy, size, verb, cost-feel — does the primary CTA earn the click?

Panoptive

Problems

  • 'pilot' implies sales-heavy commitment
  • competes with nav 'Book Demo' label
  • no visible zero-cost entry point

Value props

72Fair

Title, subtitle, hero — do they sell the product's true value?

Panoptive’s headline sellsThe continuous oversight engine for clinical trials.Turn monitoring reports and EDC data into structured findings, documented decisions, and a continuously audit-ready oversight record.

Working

  • Concrete domain nouns: EDC, findings, audit-ready
  • "Can we defend it?" hits real audit anxiety
  • Clear audience: clinical trial oversight teams

Could improve

  • No numbers or proof points in the fold
  • Hero decorates; never shows the product
  • "Engine" is abstract without a visual

Information hierarchy

76Fair

Does the design help or inhibit what the page is trying to say?

Information hierarchy annotations on the desktop capture1234
  1. Book Demo nav button — Second black filled button competes with 'Start a pilot' for the primary action — two conversion asks split intent.
  2. See how it works button — Same size and adjacency as the primary CTA; equal-weight pairing halves the pull of 'Start a pilot'.
  3. Nav link row — Product, Get Started, Careers, Contact plus Login — five exits sit above the CTA before the pitch lands.
  4. Get Started nav link — Ambiguous third conversion path duplicating the hero CTA's job with no visual hierarchy between them.